Reproducibility of measurable residual disease detection by flow cytometry in acute myeloid leukemia

Roehnert MA, Kramer M, Schadt J, Ensel P, Thiede C, Krause S, Buecklein V, Hoffmann J, Jaramillo S, Schlenk R, Roellig C, Bornhaeuser M, Mccarthy N, Freeman S, Oelschlaegel U, Von Bonin M (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 278-278

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Stefan Krause Department of Medicine 5 – Haematology and Oncology

Involved external institutions

Universitätsklinikum Carl Gustav Carus Dresden DE Germany (DE) Philipps-Universität Marburg DE Germany (DE) Universitätsklinikum Heidelberg DE Germany (DE) University Hospitals Birmingham NHS Foundation Trust GB United Kingdom (GB) Universitätsklinikum der Ludwig-Maximilians-Universität München DE Germany (DE)

How to cite

APA:

Roehnert, M.A., Kramer, M., Schadt, J., Ensel, P., Thiede, C., Krause, S.,... Von Bonin, M. (2022). Reproducibility of measurable residual disease detection by flow cytometry in acute myeloid leukemia. In ONCOLOGY RESEARCH AND TREATMENT (pp. 278-278). BASEL: KARGER.

MLA:

Roehnert, M. A., et al. "Reproducibility of measurable residual disease detection by flow cytometry in acute myeloid leukemia." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2022. 278-278.

BibTeX: Download